Bionano to Present at the Canaccord Genuity 45th Annual Growth Conference
Bionano Genomics (Nasdaq: BNGO) announced that CEO Erik Holmlin, PhD, will present at the Canaccord Genuity 45th Annual Growth Conference on August 13, 2025. The presentation is scheduled for 3:00 p.m. to 3:25 p.m. ET.
Investors can access the presentation through a webcast, and a replay will be available on the company's investor relations website for at least 30 days following the event.
Bionano Genomics (Nasdaq: BNGO) ha annunciato che il CEO Erik Holmlin, PhD, terrà una presentazione al Canaccord Genuity 45th Annual Growth Conference il 13 agosto 2025. La presentazione è programmata dalle 15:00 alle 15:25 ET.
Gli investitori potranno seguire la presentazione tramite webcast e una registrazione sarà disponibile sul sito web delle relazioni con gli investitori della società per almeno 30 giorni dopo l'evento.
Bionano Genomics (Nasdaq: BNGO) anunció que el CEO Erik Holmlin, PhD, presentará en la 45ª Conferencia Anual de Crecimiento de Canaccord Genuity el 13 de agosto de 2025. La presentación está programada de 3:00 p.m. a 3:25 p.m. ET.
Los inversores podrán acceder a la presentación a través de una transmisión en vivo, y una repetición estará disponible en el sitio web de relaciones con inversores de la compañía durante al menos 30 días después del evento.
Bionano Genomics (나스닥: BNGO)는 CEO Erik Holmlin 박사가 2025년 8월 13일에 개최되는 Canaccord Genuity 제45회 연례 성장 컨퍼런스에서 발표할 예정이라고 발표했습니다. 발표 시간은 동부 표준시 기준 오후 3시부터 3시 25분까지입니다.
투자자들은 웹캐스트를 통해 발표를 시청할 수 있으며, 발표 후 최소 30일간 회사 투자자 관계 웹사이트에서 다시보기가 제공됩니다.
Bionano Genomics (Nasdaq : BNGO) a annoncé que le PDG Erik Holmlin, PhD, présentera lors de la 45e conférence annuelle sur la croissance Canaccord Genuity le 13 août 2025. La présentation est prévue de 15h00 à 15h25 ET.
Les investisseurs pourront accéder à la présentation via un webcast, et une rediffusion sera disponible sur le site des relations investisseurs de la société pendant au moins 30 jours après l'événement.
Bionano Genomics (Nasdaq: BNGO) gab bekannt, dass CEO Erik Holmlin, PhD, auf der Canaccord Genuity 45. Jahrestagung für Wachstum am 13. August 2025 präsentieren wird. Die Präsentation ist für 15:00 bis 15:25 Uhr ET angesetzt.
Investoren können die Präsentation über einen Webcast verfolgen, und eine Wiederholung wird für mindestens 30 Tage nach der Veranstaltung auf der Investor-Relations-Website des Unternehmens verfügbar sein.
- None.
- None.
SAN DIEGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the Canaccord Genuity 45th Annual Growth Conference on August 13, 2025.
Conference & Webcast Details
| Date: | August 13, 2025 |
| Time: | 3:00 p.m. to 3:25 p.m. ET |
| Presenter: | Erik Holmlin, PhD, CEO of Bionano |
| Webcast: | Link to Register |
A replay / recording of the session will be available following the conference through the Bionano website at https://ir.bionano.com/ for at least 30 days.
About Bionano
Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through optical genome mapping (OGM) solutions, diagnostic services and software. The Company offers OGM solutions for applications across basic, translational and clinical research. The Company also offers an industry-leading, platform-agnostic genome analysis software solution, and nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. Through its Lineagen, Inc. d/b/a Bionano Laboratories business, the Company also offers OGM-based diagnostic testing services.
For more information, visit www.bionano.com or www.bionanolaboratories.com.
Bionano’s products are for research use only and not for use in diagnostic procedures.
CONTACTS
Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionano.com
Investor Relations:
Kelly Gura
Gilmartin Group
+1 (212) 229-6163
IR@bionano.com
FAQ
When is Bionano Genomics (BNGO) presenting at the Canaccord Genuity Conference?
Who will represent Bionano Genomics (BNGO) at the Canaccord Conference?
How can investors access Bionano's (BNGO) Canaccord Conference presentation?
How long will the replay of Bionano's (BNGO) Canaccord presentation be available?
